BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipopolysaccharide
,
rs2300478
,
BRCA1
,
cell-cell adhesion
,
HIV infection
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CAP2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle
Jejunum
Skeletal muscle psoas
Frontal cortex
Extraocular muscle
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Cholestasis
Dilated cardiomyopathy
Alpha-1-antitrypsin deficiency
Liver cancer
Cardiomyopathy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
N,N-dimethylformamide
tranilast
Hesperidin
5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid
Altretamine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
mir-124
SPRY4
SPRY1
TOX4
AFDN
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic…
CAP2 is a regulator of actin pointed end dynamics and myofibrillogenesis in cardiac muscle.
CA2: A Highly Connected Intrahippocampal Relay.
Disease association of cyclase-associated protein (CAP): Lessons from gene-targeted mice and human g…
Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Consequences of Respiratory Devices on Caregivers (CAP2)
Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology
Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhino…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ